Fu Cheng C - OmicsDI

Show results for

Unknown (1057)
Proteomics (44)
Transcriptomics (24)
Metabolomics (7)
Genomics (6)

Organisms

Homo sapiens (27)
Mus musculus (22)
Saccharomyces cerevisiae (7)
Ovis aries (3)
Zea mays (2)
Azumapecten farreri (2)
Sclerotinia sclerotiorum (1)
Medicago truncatula (1)
Bos taurus (1)
Pyricularia oryzae 70-15 (1)
Solanum lycopersicum (1)
Arabidopsis thaliana (1)
Macaca fascicularis fascicularis (1)
Nicotiana tabacum (1)

Organisms

Homo sapiens (1)

Repository

biostudies-arrayexpress (28)
pride (20)
iProX (19)
MetaboLights (7)
MassIVE (4)
EGA (2)
PanoramaPublic (1)
ENA (1)

Tissue

Cell culture (8)
Byssus (2)
Liver (2)
B cell (1)
Blood plasma (1)
Colon (1)
Epithelial cell (1)
Hepatocyte (1)
Leaf (1)
Neutrophil (1)
Plant cell (1)
Whole body (1)

Disease

Non-alcoholic steatohepatitis (2)
Adenocarcinoma (1)
Lymphoma (1)
Stage IV colorectal cancer (1)

Technology Type

Mass Spectrometry (20)
Shotgun proteomics (12)
Mass spectrometry (6)
Data-dependent acquisition (4)
Affinity purification coupled with mass spectrometry proteomics (2)
Bottom-up proteomics (2)
Mass spectrometry assay (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Orbitrap Exploris 480 (3)
Liquid Chromatography MS - negative - reverse phase (3)
GenePix 4000B [Axon Instruments] (1)
HiSeq X Ten (1)
Illumina HiSeq 2500 (1)
LTQ (1)
Flow injection analysis MS - (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - positive - reverse-phase (1)

Publication Date

2012 (9)
2014 (8)
2024 (7)
2025 (7)
2023 (7)
2022 (6)
2021 (6)
2020 (5)
2026 (4)
2019 (4)
2016 (3)
2015 (2)
2011 (2)
2009 (2)
2018 (2)
2010 (1)
2007 (1)

CHEBI ID

CHEBI:15864 (3)
CHEBI:16243 (3)
CHEBI:17620 (3)
CHEBI:28813 (3)
CHEBI:65004 (3)
CHEBI:90 (3)
CHEBI:121564 (2)
CHEBI:12777 (2)
CHEBI:131691 (2)
CHEBI:133478 (2)
CHEBI:134515 (2)
CHEBI:136548 (2)
CHEBI:136561 (2)
CHEBI:137056 (2)
CHEBI:138655 (2)
CHEBI:138775 (2)
CHEBI:142249 (2)
CHEBI:143821 (2)
CHEBI:145096 (2)
CHEBI:145211 (2)
CHEBI:145763 (2)
CHEBI:15401 (2)
CHEBI:15579 (2)
CHEBI:156153 (2)
CHEBI:156178 (2)
CHEBI:157713 (2)
CHEBI:15843 (2)
CHEBI:16027 (2)
CHEBI:16119 (2)
CHEBI:16220 (2)

Metabolite Name

Luteolin (3)
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (2)
(E)-1-O-Cinnamoyl-beta-D-glucose (2)
(R)-Pantothenic acid 4'-O-b-D-glucoside (2)
1,11-Undecanedicarboxylic acid (2)
1,4-Ipomeadiol (2)
1-(beta-D-Glucopyranosyloxy)-3-octanone (2)
1-Acetoxy-2-hydroxy-16-heptadecyn-4-one (2)
1-Hydroxyepiacorone (2)
1-O-Feruloylglucose (2)
10-Hydroxy-3-methoxy-1,3,5,7-cadinatetraen-9-one (2)
10-Hydroxy-8-nor-2-fenchanone glucoside (2)
11-Dehydrocorticosterone (2)
11-Hydroxyprogesterone 11-glucuronide (2)
12-Oxo-2,3-dinor-10,15-phytodienoic acid (2)
12-Oxo-20-carboxy-leukotriene B4 (2)
12-Oxo-20-trihydroxy-leukotriene B4 (2)
13-Hydroxy-9-methoxy-10-oxo-11-octadecenoic acid (2)
15beta-Hydroxydesogestrel (2)
2'',4''-Bis-O-(4-hydroxycinnamoyl)astragalin (2)
2,3-Dehydrosalvipisone (2)
2,3-Secoporrigenin (2)
2,6-Dimethoxy-4-propylphenol (2)
2,6-Dimethyl-7-octene-1,6-diol 8-O-glucoside (2)
2-(3-Hydroxyphenyl)ethanol 1'-glucoside (2)
2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] (2)
2-O-alpha-D-Galactopyranosyl-1-deoxynojirimycin (2)
20-Trihydroxy-leukotriene-B4 (2)
3'-Hydroxy-T2 Toxin (2)
3'-Prenylapigenin 7-[rhamnosyl-(1->6)-glucoside] (2)

First Public Date

2017 (1)

Study type

Transcription profiling by array (15)
RNA-seq of coding RNA (5)
ChIP-seq (2)
RNA-seq of non coding RNA (2)
ChIP-chip by tiling array (1)
Comparative genomic hybridization by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2025 (167)
2022 (142)
2023 (124)
2021 (118)
2024 (117)
2020 (83)
2019 (62)
2018 (61)
2017 (40)
2026 (34)
2016 (33)
2015 (33)
2014 (22)
2012 (20)
2013 (11)
2011 (7)
2010 (3)
2007 (3)
2002 (3)
2009 (2)

Lab affiliation

Cornell University (2)
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China (2)
1Department of Pathology, Dana-Farber/Harvard Cancer Center, PhD Program in Immunology, Harvard Medical School; Department of Laboratory Medicine, Boston Children's Hospital, Enders Research Building, Room 811, Boston, MA, 02115, USA (1)
Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun, China. (1)
China State Institute of Pharmaceutical Industry (1)
College of Marine Life Sciences, Ocean University of China, Qingdao, China (1)
Department of Obstetrics/Gynecology, Joint Laboratory of Reproductive Medicine (SCU-CUHK), Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, China. (1)
Institute of Biomedical Sciences, Academia Sinica (1)
Institute of Plant Virology, Ningbo University, Ningbo, China (1)
Institution of Cellular and Organismic Biology Academia Sinica (1)
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China (1)
Key Laboratory of Horticultural Plant Biology (MOE), Huazhong Agricultural University, Wuhan, 430070, China Hubei Hongshan Laboratory, Wuhan, 430070, China (1)
Moffitt Cancer Center (1)
Ocean University of China (1)
School of Medicine, Fu Jen Catholic University, New Taipei, Taiwan (1)
Sichuan University,West China Hospital (1)
The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China; The First Affiliated Hospital of Harbin Medical University (1)
The First Hospital of Jilin University (1)

Previous page
1 / 114
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 114
Next page

Sort by:

Relevance

Page size

miRNA profiling data of mouse bone marrow samples four days post 5-FU treatment versus untreated controls

To identify miRNAs that regulate hematopoietic response after 5-FU-induced injury, we analyzed miRNA expression changes in bone marrow cells from mice with or without 5-FU treatment. Global miRNA expression profiling of the 5-FU and untreated cohorts showed that 92 miRNAs (among 168 that passed the ...

ORGANISM(S): Mus musculus

2012-09-24 | E-GEOD-39211 | biostudies-arrayexpress

The Cervical Lymph Node Positive Metastatic Probability Is a Significant Predictor of Survival for Oral Squamous Cell Carcinoma—A Nationwide Study

Not available

S-EPMC12385004 | biostudies-literature

Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.

Not available

S-EPMC8822242 | biostudies-literature

Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment.

Not available

S-EPMC7491101 | biostudies-literature

Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis.

Not available

S-EPMC9083850 | biostudies-literature

5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients.

Not available

S-EPMC7188923 | biostudies-literature

Bacillus coagulans 198 and L-glutamine in combination attenuated intestinal mucositis in a 5-FU-induced BALB/c mouse model via modulation of gut microbial community structure and diversity.

Not available

S-EPMC12039531 | biostudies-literature

Early Detection of Dementia Through Spectralis Optical Coherence Tomography in a Taiwanese Cohort

Not available

S-EPMC12939327 | biostudies-literature

Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis.

Not available

S-EPMC12639605 | biostudies-literature

The E3 ubiquitin ligase FBXL18 stabilizes BST2 to promote inflammation in RABV-infected astrocytes

we identify the ubiquitnation sites of BST2 and used quantitative proteomic analysis to compare protein abundance between WT MA-C cells and those that have received FBXL18-specific siRNAs

ORGANISM(S): Mus musculus (Mouse)

2025-12-29 | PXD058432 | Pride

Bst2 ubiquitination，fbxl18 proteomics

Previous page
1 / 114
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 114
Next page

Sort by:

Relevance

Page size

1139 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets